Strategies Targeting DNA Topoisomerase I in Cancer Chemotherapy: Camptothecins, Nanocarriers for Camptothecins, Organic Non-Camptothecin Compounds and Metal Complexes

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|17|16|1928-1939

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.16, 2016-12, pp. : 1928-1939

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting DNA Topoisomerase I with Non-Camptothecin Poisons

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1238-1257

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 305-320

Bentham Science Publishers

Access to resources Recommend Favorite

Non-camptothecin topoisomerase I active compounds as potential anticancer agents

By Long B.H.   Balasubramanian B.N.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 635-666

Informa Healthcare

Access to resources Recommend Favorite

New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4389-4409

Bentham Science Publishers

Access to resources Recommend Favorite

Camptothecin works are still in progress. The Camptothecins: from Discovery to the Patient

By Capranico G.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. : 445-446

Elsevier

Access to resources Recommend Favorite